Main Page: Difference between revisions
Mauricezaki (talk | contribs) today's topic update |
Mauricezaki (talk | contribs) No edit summary |
||
| Line 15: | Line 15: | ||
* '''Expertise''': Congress has repeatedly passed bills that do substantial harm to the American pharmaceutical industry, with negative ramifications for pharmaceutical workers, consumers, and the country as a whole. Allowing PhRMA to lobby congress gives them a direct line to convince them to make better decisions for the country and for every stakeholder in the pharmaceutical industry. Ethical framing: Utilitarian | * '''Expertise''': Congress has repeatedly passed bills that do substantial harm to the American pharmaceutical industry, with negative ramifications for pharmaceutical workers, consumers, and the country as a whole. Allowing PhRMA to lobby congress gives them a direct line to convince them to make better decisions for the country and for every stakeholder in the pharmaceutical industry. Ethical framing: Utilitarian | ||
* '''Benefit to society''': While arguments about profiteering are valid, the pharma industry ultimately works to save lives and improve quality of life for tens of millions of Americans. The goals of the pharma industry are goals that all Americans should share, and allowing them to lobby congress helps them achieve an ethically sound goal as long as regulation exists to ensure that profiteering isn’t the primary goal of the lobbyists. Ethical framing: Deontological (rooted in social contract) | * '''Benefit to society''': While arguments about profiteering are valid, the pharma industry ultimately works to save lives and improve quality of life for tens of millions of Americans. The goals of the pharma industry are goals that all Americans should share, and allowing them to lobby congress helps them achieve an ethically sound goal as long as regulation exists to ensure that profiteering isn’t the primary goal of the lobbyists. Ethical framing: Deontological (rooted in social contract) | ||
<!-- | |||
* '''Systemic Fairness''': While there are issues with pharmaceutical lobbying that could be regulated better, it would be unfair to specifically target pharmaceutical industry, who’s goals and function contribute to improving the health and well-being of everybody who needs healthcare, while ignoring other corporate lobbying groups. Zooming out even further, specifically arguing against corporate lobby groups while ignoring other lobby groups like nonprofits, unions, policy thinktanks, and international groups unnecessarily targets companies. Ethical framing: Deontological (fairness based) | * '''Systemic Fairness''': While there are issues with pharmaceutical lobbying that could be regulated better, it would be unfair to specifically target pharmaceutical industry, who’s goals and function contribute to improving the health and well-being of everybody who needs healthcare, while ignoring other corporate lobbying groups. Zooming out even further, specifically arguing against corporate lobby groups while ignoring other lobby groups like nonprofits, unions, policy thinktanks, and international groups unnecessarily targets companies. Ethical framing: Deontological (fairness based) | ||
* '''Private-Public Cooperation''': Allowing pharmaceutical companies to lobby congress and federal agencies helps streamline the process of private-public collaboration in pharmaceutical and related healthcare applications. Private-public collaboration has produced societal projects with the greatest impact on improving qualify of life in America, and hindering corporate lobbying is a move in the wrong direction for creating more of these projects. Ethical framing: Both utilitarian and deontological (duty/social contract) | * '''Private-Public Cooperation''': Allowing pharmaceutical companies to lobby congress and federal agencies helps streamline the process of private-public collaboration in pharmaceutical and related healthcare applications. Private-public collaboration has produced societal projects with the greatest impact on improving qualify of life in America, and hindering corporate lobbying is a move in the wrong direction for creating more of these projects. Ethical framing: Both utilitarian and deontological (duty/social contract) | ||
--> | |||
* Lobbying practices have an inherent self-preserving interest given most groups have direct ties to the profit-driven industry. While they provide expertise for ongoing research, their profit-driven biases can result in presenting incomplete findings on treatments, promoting high drug prices, and relaxing drug testing & distribution standards. This self-serving behavior can be demonstrated by the staggering amounts invested in campaign contributions and continually climbing U.S. drug prices. | * Lobbying practices have an inherent self-preserving interest given most groups have direct ties to the profit-driven industry. While they provide expertise for ongoing research, their profit-driven biases can result in presenting incomplete findings on treatments, promoting high drug prices, and relaxing drug testing & distribution standards. This self-serving behavior can be demonstrated by the staggering amounts invested in campaign contributions and continually climbing U.S. drug prices. | ||
|- | |- | ||
Revision as of 12:33, 7 April 2025
Welcome to Unifiers' Movementthe Balanced Arguments to Global Issues. | ||||
|---|---|---|---|---|
From Today's Controversial Topic
Pharmaceutical_Lobbying, Pharmaceutical industry lobbying comprises one of the most powerful and high spending corporate lobby groups in the United States, spearheaded by the PhRMA industry group. Doctoral students were asked to take "Pro", "Con", and "In Between" positions regarding the usefulness and harm of Pharmaceutical Lobbying. (Full topic...) Credit: Morrisson, D.; Williamson, L. (authors and sources listed alphabetically) |
Today's Topic Discussion
| |||
|
About The Unifiers’ Movement (UM)
UM is a global non-profit organization which aims to engage interested scholars with differing views in examining important global societal issues and developing publishable respected arguments that can serve as trustworthy sources to individuals, families, organizations, governments, etc., to express their own informed positions on the issue. These positions will continue being re-examined as new evidence becomes available and being re-adjusted in addendum publications so that they can remain relevant and current. UM will know it is doing its job when it gets closest to achieving unification through a robust balance that becomes increasingly difficult to tip. (Read more...) | ||||
Unifiers' Movement Book
| ||||
